Dongguan Yikang Medical Protection Articles Co., Ltd. – Trademark Portfolio

Entity Type: 16

Dongguan Yikang Medical Protection Articles Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include MESARI. The owner is based in Dongguan, Guangdong.

Building 1, No. 10, Qingfeng Road,

Qinghutou, Tangxia Town,

Dongguan, Guangdong 523000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MESARI
MESARI
Registered 2022

Trademark Classifications

Dongguan Yikang Medical Protection Articles Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does Dongguan Yikang Medical Protection Articles Co., Ltd. have?

Dongguan Yikang Medical Protection Articles Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Dongguan Yikang Medical Protection Articles Co., Ltd. file in?

Dongguan Yikang Medical Protection Articles Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 25 (Clothing). Class 25 covers clothing, footwear, headgear.

What are Dongguan Yikang Medical Protection Articles Co., Ltd.'s most well-known trademarks?

Dongguan Yikang Medical Protection Articles Co., Ltd.'s registered trademark portfolio includes well-known marks such as MESARI. These are among 1 currently registered trademark in the portfolio.

What is Dongguan Yikang Medical Protection Articles Co., Ltd.'s trademark registration success rate?

Dongguan Yikang Medical Protection Articles Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.